BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gupta N, Wang X, Wen X, Moran P, Paluch M, Hass PE, Heidersbach A, Haley B, Kirchhofer D, Brezski RJ, Peterson AS, Scales SJ. Domain-Specific Antibodies Reveal Differences in the Membrane Topologies of Apolipoprotein L1 in Serum and Podocytes. J Am Soc Nephrol 2020;31:2065-82. [PMID: 32764138 DOI: 10.1681/ASN.2019080830] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Daneshpajouhnejad P, Kopp JB, Winkler CA, Rosenberg AZ. The evolving story of apolipoprotein L1 nephropathy: the end of the beginning. Nat Rev Nephrol 2022. [PMID: 35217848 DOI: 10.1038/s41581-022-00538-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Kruzel-davila E, Bavli-kertselli I, Ofir A, Cheatham AM, Shemer R, Zaknoun E, Chornyy S, Tabachnikov O, Davis SE, Khatua AK, Skorecki K, Popik W. Endoplasmic reticulum-translocation is essential for APOL1 cellular toxicity. iScience 2022;25:103717. [DOI: 10.1016/j.isci.2021.103717] [Reference Citation Analysis]
3 Ultsch M, Holliday MJ, Gerhardy S, Moran P, Scales SJ, Gupta N, Oltrabella F, Chiu C, Fairbrother W, Eigenbrot C, Kirchhofer D. Structures of the ApoL1 and ApoL2 N-terminal domains reveal a non-classical four-helix bundle motif. Commun Biol 2021;4:916. [PMID: 34316015 DOI: 10.1038/s42003-021-02387-5] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
4 Freedman BI, Kopp JB, Sampson MG, Susztak K. APOL1 at 10 years: progress and next steps. Kidney Int 2021;99:1296-302. [PMID: 33794228 DOI: 10.1016/j.kint.2021.03.013] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
5 Bruggeman LA, Sedor JR, O'Toole JF. Apolipoprotein L1 and mechanisms of kidney disease susceptibility. Curr Opin Nephrol Hypertens 2021;30:317-23. [PMID: 33767059 DOI: 10.1097/MNH.0000000000000704] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
6 Blazer A, Dey ID, Nwaukoni J, Reynolds M, Ankrah F, Algasas H, Ahmed T, Divers J. Apolipoprotein L1 risk genotypes in Ghanaian patients with systemic lupus erythematosus: a prospective cohort study. Lupus Sci Med 2021;8:e000460. [PMID: 33461980 DOI: 10.1136/lupus-2020-000460] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
7 Scales SJ, Gupta N, De Mazière AM, Posthuma G, Chiu CP, Pierce AA, Hötzel K, Tao J, Foreman O, Koukos G, Oltrabella F, Klumperman J, Lin W, Peterson AS. Apolipoprotein L1-Specific Antibodies Detect Endogenous APOL1 inside the Endoplasmic Reticulum and on the Plasma Membrane of Podocytes. J Am Soc Nephrol 2020;31:2044-64. [PMID: 32764142 DOI: 10.1681/ASN.2019080829] [Cited by in Crossref: 12] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]